Involvement of HVEM receptor in activation of nuclear factor κB by herpes simplex virus 1 glycoprotein D

The UV‐inactivated herpes simplex virus 1 (HSV‐1) and glycoprotein D (gD) of HSV‐1 have been shown to activate nuclear factor κB (NF‐κB) in U937 cells, but mechanisms involved in this activation have not been elucidated. Here we report that: (i) UV‐inactivated HSV‐1 induced an increased NF‐κB activation in cells expressing human HVEM (for herpesvirus entry mediator) at surface level, naturally or following stable transfection, but not in cells in which this receptor was not detected by flow cytometry analysis, (ii) treatment with soluble gD induced a dose‐dependent NF‐κB activation in THP‐1 cells naturally expressing HVEM, and a monoclonal antibody that prevents binding of gD to HVEM significantly reduced NF‐κB activation by soluble gD in the same cells, (iii) coculture with transfectants expressing wild‐type gD on their surface induced an approximately twofold increase in NF‐κB activation in cells naturally expressing HVEM, while coculture with transfectants expressing a mutated form of gD, lacking its capability to bind HVEM, did not induce a similar effect and (iv) treatment with soluble gD induced a dose‐dependent NF‐κB activation in CHO transfectants expressing HVEM, but not in control CHO transfectants lacking any functional gD receptor. Overall, these results establish that HVEM is involved in NF‐κB activation by HSV‐1 gD.

[1]  G. Freeman,et al.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator , 2008, Nature Immunology.

[2]  C. Benedict,et al.  The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells1 , 2008, The Journal of Immunology.

[3]  B. Chain,et al.  Understanding HSV‐1 entry glycoproteins , 2007, Reviews in medical virology.

[4]  N. Perkins,et al.  Transcriptional profiling of the LPS induced NF-κB response in macrophages , 2007, BMC Immunology.

[5]  S. Grelli,et al.  Signaling Pathway Used by HSV‐1 to Induce NF‐κB Activation , 2007 .

[6]  S. Bachenheimer,et al.  Herpes Simplex Virus Type 1 ICP27-Dependent Activation of NF-κB , 2006, Journal of Virology.

[7]  B. Marinari,et al.  Herpes Simplex Virus Disrupts NF-κB Regulation by Blocking Its Recruitment on the IκBα Promoter and Directing the Factor on Viral Genes* , 2006, Journal of Biological Chemistry.

[8]  B. Kwon,et al.  LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM , 2006, Journal of leukocyte biology.

[9]  P. Spear,et al.  Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. , 2006, Virology.

[10]  D. Wiley,et al.  Structure of unliganded HSV gD reveals a mechanism for receptor‐mediated activation of virus entry , 2005, The EMBO journal.

[11]  N. Novak,et al.  Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells , 2005, Clinical and experimental immunology.

[12]  C. Benedict,et al.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Newton,et al.  Dendritic cells in viral pathogenesis: protective or defective? , 2005, International journal of experimental pathology.

[14]  A. Fuller,et al.  Herpes Simplex Virus Entry Mediator Associates in Infected Cells in a Complex with Viral Proteins gD and at Least gH , 2005, Journal of Virology.

[15]  P. Newburger,et al.  The role of toll-like receptors in herpes simplex infection in neonates. , 2005, The Journal of infectious diseases.

[16]  K. Pfeffer,et al.  The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. , 2005, The Journal of clinical investigation.

[17]  Bianhong Zhang,et al.  Herpes virus proteins ICP0 and BICP0 can activate NF-κB by catalyzing IκBα ubiquitination , 2005 .

[18]  Wenjun Ouyang,et al.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Bachenheimer,et al.  Efficient Replication by Herpes Simplex Virus Type 1 Involves Activation of the IκB Kinase-IκB-p65 Pathway , 2004, Journal of Virology.

[20]  P. Spear,et al.  Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Weiran Zhang,et al.  Cells Lacking NF-κB or in Which NF-κB Is Not Activated Vary with Respect to Ability To Sustain Herpes Simplex Virus 1 Replication and Are Not Susceptible to Apoptosis Induced by a Replication-Incompetent Mutant Virus , 2004, Journal of Virology.

[22]  B. Chain,et al.  Herpes Simplex Virus Type-1-Induced Activation of Myeloid Dendritic Cells: The Roles of Virus Cell Interaction and Paracrine Type I IFN Secretion1 , 2004, The Journal of Immunology.

[23]  R. Eisenberg,et al.  Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. , 2004, Virology.

[24]  P. Spear,et al.  Herpes simplex virus: receptors and ligands for cell entry , 2004, Cellular microbiology.

[25]  A. Bowie,et al.  Viral appropriation of apoptotic and NF‐κB signaling pathways , 2004, Journal of cellular biochemistry.

[26]  B. Kwon,et al.  High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases , 2003, Experimental & Molecular Medicine.

[27]  Weiran Zhang,et al.  Activation of NF-κB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Longnecker,et al.  Herpesvirus Entry: an Update , 2003, Journal of Virology.

[29]  M. Ciotti,et al.  Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis , 2003, Journal of Biological Chemistry.

[30]  D. Wiley,et al.  Structure-Based Mutagenesis of Herpes Simplex Virus Glycoprotein D Defines Three Critical Regions at the gD-HveA/HVEM Binding Interface , 2003, Journal of Virology.

[31]  J. Blaho,et al.  NF-κB Is Required for Apoptosis Prevention during Herpes Simplex Virus Type 1 Infection , 2003, Journal of Virology.

[32]  S. Paludan,et al.  Activation of NF-κB in Virus-Infected Macrophages Is Dependent on Mitochondrial Oxidative Stress and Intracellular Calcium: Downstream Involvement of the Kinases TGF-β-Activated Kinase 1, Mitogen-Activated Kinase/Extracellular Signal-Regulated Kinase Kinase 1, and IκB Kinase 1 , 2003, The Journal of Immunology.

[33]  C. Amici,et al.  NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .

[34]  J. Ledermann,et al.  Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. , 2003, The Journal of infectious diseases.

[35]  B. Kwon,et al.  Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation. , 2002, Molecules and cells.

[36]  B. Roizman,et al.  The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Wiley,et al.  Structure-Based Analysis of the Herpes Simplex Virus Glycoprotein D Binding Site Present on Herpesvirus Entry Mediator HveA (HVEM) , 2002, Journal of Virology.

[38]  H. Matsui,et al.  LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD. , 2001, Biochemical and biophysical research communications.

[39]  C. Amici,et al.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. , 2001, The Journal of biological chemistry.

[40]  D. Wiley,et al.  Herpes simplex virus glycoprotein D bound to the human receptor HveA. , 2001, Molecular cell.

[41]  W. O'brien,et al.  Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  I. Lehman,et al.  Replication of Herpes Simplex Virus DNA* , 1999, The Journal of Biological Chemistry.

[43]  P. Young,et al.  Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth* , 1998, The Journal of Biological Chemistry.

[44]  R. Eisenberg,et al.  Functional Region IV of Glycoprotein D from Herpes Simplex Virus Modulates Glycoprotein Binding to the Herpesvirus Entry Mediator , 1998, Journal of Virology.

[45]  W. Miller,et al.  Herpes Simplex Virus Type 1 Induction of Persistent NF-κB Nuclear Translocation Increases the Efficiency of Virus Replication , 1998 .

[46]  R. Eisenberg,et al.  Monoclonal Antibodies to Distinct Sites on Herpes Simplex Virus (HSV) Glycoprotein D Block HSV Binding to HVEM , 1998, Journal of Virology.

[47]  T. Ayres,et al.  Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1* , 1997, The Journal of Biological Chemistry.

[48]  B. Kwon,et al.  A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation* , 1997, The Journal of Biological Chemistry.

[49]  W. J. Boyle,et al.  ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5* , 1997, The Journal of Biological Chemistry.

[50]  P. Spear,et al.  Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family , 1996, Cell.

[51]  R. Eisenberg,et al.  Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D , 1996, Journal of virology.

[52]  P. Spear,et al.  Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference , 1995, Journal of virology.

[53]  J. Esko,et al.  Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans , 1992, The Journal of cell biology.

[54]  C. Heilman,et al.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D , 1989, Journal of virology.

[55]  F. Carp,et al.  On Replication , 1957 .

[56]  B. Marinari,et al.  Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes. , 2006, The Journal of biological chemistry.

[57]  S. Bachenheimer,et al.  Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. , 2004, Journal of virology.

[58]  S. Paludan,et al.  Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase. , 2003, Journal of immunology.

[59]  W. Miller,et al.  Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication. , 1998, Virology.